Heidi Splete

NEWPORT BEACH, CALIF. – There is a role for topical cidofovir in the treatment of recalcitrant warts in children, Dr. James R. Treat said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

The drug is not to be used as a first, second, or even third-line option, but can be effective in stubborn cases, said Dr. Treat of Children’s Hospital of Philadelphia.

In an interview at the meeting, Dr. Treat explained how and when he incorporates topical cidofovir and other strategies into managing verruca vulgaris when other treatments fail.

Dr. Treat had no relevant financial conflicts to disclose.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF. – There is a role for topical cidofovir in the treatment of recalcitrant warts in children, Dr. James R. Treat said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

The drug is not to be used as a first, second, or even third-line option, but can be effective in stubborn cases, said Dr. Treat of Children’s Hospital of Philadelphia.

In an interview at the meeting, Dr. Treat explained how and when he incorporates topical cidofovir and other strategies into managing verruca vulgaris when other treatments fail.

Dr. Treat had no relevant financial conflicts to disclose.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF. – There is a role for topical cidofovir in the treatment of recalcitrant warts in children, Dr. James R. Treat said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

The drug is not to be used as a first, second, or even third-line option, but can be effective in stubborn cases, said Dr. Treat of Children’s Hospital of Philadelphia.

In an interview at the meeting, Dr. Treat explained how and when he incorporates topical cidofovir and other strategies into managing verruca vulgaris when other treatments fail.

Dr. Treat had no relevant financial conflicts to disclose.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF.– “The group we worry about are the 1- to 7-year-olds,” when it comes to new-onset acne, Dr. Sheila Fallon Friedlander said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

In an interview at the meeting, Dr. Friedlander, a professor at the University of California, San Diego, explained the additional clinical signs that can indicate a serious problem, and what questions to ask parents.

Tune in for her tips on how to evaluate children aged 1-7 years with acne.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF.– “The group we worry about are the 1- to 7-year-olds,” when it comes to new-onset acne, Dr. Sheila Fallon Friedlander said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

In an interview at the meeting, Dr. Friedlander, a professor at the University of California, San Diego, explained the additional clinical signs that can indicate a serious problem, and what questions to ask parents.

Tune in for her tips on how to evaluate children aged 1-7 years with acne.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF.– “The group we worry about are the 1- to 7-year-olds,” when it comes to new-onset acne, Dr. Sheila Fallon Friedlander said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

In an interview at the meeting, Dr. Friedlander, a professor at the University of California, San Diego, explained the additional clinical signs that can indicate a serious problem, and what questions to ask parents.

Tune in for her tips on how to evaluate children aged 1-7 years with acne.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF.– Patients with discoid lupus should be checked routinely for systemic disease, but complete autoantibody studies aren’t necessary for those patients with a prior work-up and a documented negative antinuclear antibodies, according to Dr. Ruth Ann Vleugels.

“The reason why we are doing these investigations is because between 5% and up to about 20% of our discoid lupus patients can develop systemic disease,” said Dr. Vleugels of Brigham and Women’s Hospital in Boston, Mass. Some patients don’t develop symptoms until years later, she noted.

In an interview at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar, Dr. Vleugels shared her protocol for managing discoid lupus patients. She had no financial conflicts to disclose. SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF.– Patients with discoid lupus should be checked routinely for systemic disease, but complete autoantibody studies aren’t necessary for those patients with a prior work-up and a documented negative antinuclear antibodies, according to Dr. Ruth Ann Vleugels.

“The reason why we are doing these investigations is because between 5% and up to about 20% of our discoid lupus patients can develop systemic disease,” said Dr. Vleugels of Brigham and Women’s Hospital in Boston, Mass. Some patients don’t develop symptoms until years later, she noted.

In an interview at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar, Dr. Vleugels shared her protocol for managing discoid lupus patients. She had no financial conflicts to disclose. SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF.– Patients with discoid lupus should be checked routinely for systemic disease, but complete autoantibody studies aren’t necessary for those patients with a prior work-up and a documented negative antinuclear antibodies, according to Dr. Ruth Ann Vleugels.

“The reason why we are doing these investigations is because between 5% and up to about 20% of our discoid lupus patients can develop systemic disease,” said Dr. Vleugels of Brigham and Women’s Hospital in Boston, Mass. Some patients don’t develop symptoms until years later, she noted.

In an interview at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar, Dr. Vleugels shared her protocol for managing discoid lupus patients. She had no financial conflicts to disclose. SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

BALTIMORE – Methods to prevent and treat migraines are lacking, but monoclonal antibodies and the calcitonin receptor system are showing promise, according to Dr. Peter Goadsby of the University of California, San Francisco.

“It’s an awful mishmash of things we have to offer,” Dr. Goadsby said at the annual meeting of the American Neurological Association. However, data presented at the meeting suggest that new options may be on the horizon.

In an interview at the meeting, Dr. Goadsby explained details of several studies that showed dramatic results, and the “tantalizing” implications for patients.

[email protected]

BALTIMORE – Methods to prevent and treat migraines are lacking, but monoclonal antibodies and the calcitonin receptor system are showing promise, according to Dr. Peter Goadsby of the University of California, San Francisco.

“It’s an awful mishmash of things we have to offer,” Dr. Goadsby said at the annual meeting of the American Neurological Association. However, data presented at the meeting suggest that new options may be on the horizon.

In an interview at the meeting, Dr. Goadsby explained details of several studies that showed dramatic results, and the “tantalizing” implications for patients.

[email protected]

BALTIMORE – Methods to prevent and treat migraines are lacking, but monoclonal antibodies and the calcitonin receptor system are showing promise, according to Dr. Peter Goadsby of the University of California, San Francisco.

“It’s an awful mishmash of things we have to offer,” Dr. Goadsby said at the annual meeting of the American Neurological Association. However, data presented at the meeting suggest that new options may be on the horizon.

In an interview at the meeting, Dr. Goadsby explained details of several studies that showed dramatic results, and the “tantalizing” implications for patients.

[email protected]

NEWPORT BEACH, CALIF. – The approval of apremilast (Otezla) for the treatment of moderate to severe plaque psoriasis will make a significant impact on patient care, Dr. Alan Menter of Baylor University Medical Center, Dallas, Tex., said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

“I think where this drug is going to have a role is ... patients who are risk averse to needles, have contraindications to TNF-alpha agents ... patients who want a drug with minimal to no long-term side effects,” with the exception of the significant incidence of diarrhea within the early weeks of starting the drug, Dr. Menter explained. Clinicians should explain the risk of diarrhea to patients, and help them get through the first few months. The diarrhea “definitely does vanish with time,” he said. Overall, the risk of side effects is extremely low, he noted. “It is probably the safest drug we have approved for psoriasis today.”

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF. – The approval of apremilast (Otezla) for the treatment of moderate to severe plaque psoriasis will make a significant impact on patient care, Dr. Alan Menter of Baylor University Medical Center, Dallas, Tex., said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

“I think where this drug is going to have a role is ... patients who are risk averse to needles, have contraindications to TNF-alpha agents ... patients who want a drug with minimal to no long-term side effects,” with the exception of the significant incidence of diarrhea within the early weeks of starting the drug, Dr. Menter explained. Clinicians should explain the risk of diarrhea to patients, and help them get through the first few months. The diarrhea “definitely does vanish with time,” he said. Overall, the risk of side effects is extremely low, he noted. “It is probably the safest drug we have approved for psoriasis today.”

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF. – The approval of apremilast (Otezla) for the treatment of moderate to severe plaque psoriasis will make a significant impact on patient care, Dr. Alan Menter of Baylor University Medical Center, Dallas, Tex., said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

“I think where this drug is going to have a role is ... patients who are risk averse to needles, have contraindications to TNF-alpha agents ... patients who want a drug with minimal to no long-term side effects,” with the exception of the significant incidence of diarrhea within the early weeks of starting the drug, Dr. Menter explained. Clinicians should explain the risk of diarrhea to patients, and help them get through the first few months. The diarrhea “definitely does vanish with time,” he said. Overall, the risk of side effects is extremely low, he noted. “It is probably the safest drug we have approved for psoriasis today.”

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF. – Do more women today really have acne? Or are they simply more likely to seek help because they learn of new and better medications?

Acne often causes more psychosocial and psychological stress in adult women than in men or adolescents, Dr. Hilary Baldwin of SUNY Downstate Medical Center, Brooklyn, N.Y., said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

In an interview at the meeting, Dr. Baldwin explained what makes the treatment of acne in adult women distinct from acne treatment for men and adolescents, and what underused medications can yield success.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF. – Do more women today really have acne? Or are they simply more likely to seek help because they learn of new and better medications?

Acne often causes more psychosocial and psychological stress in adult women than in men or adolescents, Dr. Hilary Baldwin of SUNY Downstate Medical Center, Brooklyn, N.Y., said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

In an interview at the meeting, Dr. Baldwin explained what makes the treatment of acne in adult women distinct from acne treatment for men and adolescents, and what underused medications can yield success.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

NEWPORT BEACH, CALIF. – Do more women today really have acne? Or are they simply more likely to seek help because they learn of new and better medications?

Acne often causes more psychosocial and psychological stress in adult women than in men or adolescents, Dr. Hilary Baldwin of SUNY Downstate Medical Center, Brooklyn, N.Y., said at Skin Disease Education Foundation’s Women’s & Pediatric Dermatology Seminar.

In an interview at the meeting, Dr. Baldwin explained what makes the treatment of acne in adult women distinct from acne treatment for men and adolescents, and what underused medications can yield success.

SDEF and this news organization are owned by Frontline Medical Communications.

[email protected]

PHILADELPHIA – How would your hospital handle an Ebola patient? Ask Dr. Bruce Ribner.

At ID Week 2014 in Philadelphia, Dr. Ribner, medical director of Emory University Hospital’s serious communicable diseases unit in Atlanta, gave a detailed account of his hospital’s management of the first two American patients treated at Emory after contracting the disease while working in Africa.

[email protected]

PHILADELPHIA – How would your hospital handle an Ebola patient? Ask Dr. Bruce Ribner.

At ID Week 2014 in Philadelphia, Dr. Ribner, medical director of Emory University Hospital’s serious communicable diseases unit in Atlanta, gave a detailed account of his hospital’s management of the first two American patients treated at Emory after contracting the disease while working in Africa.

[email protected]

PHILADELPHIA – How would your hospital handle an Ebola patient? Ask Dr. Bruce Ribner.

At ID Week 2014 in Philadelphia, Dr. Ribner, medical director of Emory University Hospital’s serious communicable diseases unit in Atlanta, gave a detailed account of his hospital’s management of the first two American patients treated at Emory after contracting the disease while working in Africa.

[email protected]

EDINBURGH – Variants in the pigment-associated MC1R gene have been implicated in an increased risk for melanoma and nonmelanoma skin cancers, although the extent of that risk has been inconsistent across studies, according to Dr. Eugene Healy of the University of Southampton (England). In an interview at the 15th World Congress on Cancers of the Skin sponsored by the Skin Cancer Foundation, Dr. Healy discussed how the MC1R gene variants might impact skin cancer risk and the challenges of pinning down genetic data into practical applications for patients.

[email protected]

EDINBURGH – Variants in the pigment-associated MC1R gene have been implicated in an increased risk for melanoma and nonmelanoma skin cancers, although the extent of that risk has been inconsistent across studies, according to Dr. Eugene Healy of the University of Southampton (England). In an interview at the 15th World Congress on Cancers of the Skin sponsored by the Skin Cancer Foundation, Dr. Healy discussed how the MC1R gene variants might impact skin cancer risk and the challenges of pinning down genetic data into practical applications for patients.

[email protected]

EDINBURGH – Variants in the pigment-associated MC1R gene have been implicated in an increased risk for melanoma and nonmelanoma skin cancers, although the extent of that risk has been inconsistent across studies, according to Dr. Eugene Healy of the University of Southampton (England). In an interview at the 15th World Congress on Cancers of the Skin sponsored by the Skin Cancer Foundation, Dr. Healy discussed how the MC1R gene variants might impact skin cancer risk and the challenges of pinning down genetic data into practical applications for patients.

[email protected]

EDINBURGH – When your patient says he or she wants to die, what do you do?

There’s no single answer, but asking the right questions can help patients find peace as well as perspective, according to Dr. Ilora Finlay, who spoke at the 15th World Congress on Cancers of the Skin about the types of conversations and seemingly small actions that can make a big difference for patients coping with advanced cancer.

In an interview at the meeting, Dr. Finlay shared some of her expertise from decades of clinical experience in palliative care.

The congress was sponsored by the Skin Cancer Foundation.

[email protected]

EDINBURGH – When your patient says he or she wants to die, what do you do?

There’s no single answer, but asking the right questions can help patients find peace as well as perspective, according to Dr. Ilora Finlay, who spoke at the 15th World Congress on Cancers of the Skin about the types of conversations and seemingly small actions that can make a big difference for patients coping with advanced cancer.

In an interview at the meeting, Dr. Finlay shared some of her expertise from decades of clinical experience in palliative care.

The congress was sponsored by the Skin Cancer Foundation.

[email protected]

EDINBURGH – When your patient says he or she wants to die, what do you do?

There’s no single answer, but asking the right questions can help patients find peace as well as perspective, according to Dr. Ilora Finlay, who spoke at the 15th World Congress on Cancers of the Skin about the types of conversations and seemingly small actions that can make a big difference for patients coping with advanced cancer.

In an interview at the meeting, Dr. Finlay shared some of her expertise from decades of clinical experience in palliative care.

The congress was sponsored by the Skin Cancer Foundation.

[email protected]

WASHINGTON – The best way to fight the flu is to “get a flu shot this year and every year,” said Dr. Thomas Frieden.

Last year was a bad year, especially for adults aged 18-64 years, who had their highest rate of flu-related hospitalizations since the 2009 pandemic, Dr. Frieden, director of the Centers for Disease Control and Prevention, Atlanta, said at a recent press conference sponsored by the National Foundation for Infectious Diseases.

©CDC

Approximately 150 million doses of flu vaccine are expected to be available this season, and there should be plenty to go around, he emphasized.

The CDC has a three-pronged message for patients and health care providers: Get vaccinated, stay home if you are sick, and take medications if they are prescribed.

Overall vaccination coverage of the U.S. population aged 6 months and older was 46% in 2013-2014, which was a slight increase from the previous year. The upward trend is encouraging, Dr. Frieden said, especially the 65% of adults aged 65 and older and 70% of children aged 6 months to 5 years who received flu vaccination last year, but there is certainly room for improvement.

Fortunately, there are more flu vaccine options, and places to get them, than ever before, said Dr. William Schaffner, professor and chairman of the department of preventive medicine at Vanderbilt University, Nashville, past president of the NFID. Choices include the traditional intramuscular shot, an intradermal version with a smaller needle, nasal spray, an egg-free vaccine, and a high-dose vaccine especially for adults aged 65 and older, he said.

This year, for the first time, the CDC recommends the nasal spray as the preferred flu vaccination method for children aged 2-8 years if they have no contraindications, said Dr. Paul A. Offit, chief of the division of infectious diseases and director of the vaccine education center of the Children’s Hospital of Philadelphia. Parents, however, should not postpone vaccinating their children with a different vaccine if the spray is not available, since all are effective, he said.

Although flu vaccination rates in children are up, coverage of pregnant women held steady, said Dr. Laura E. Riley, medical director of labor and delivery in the obstetrics service of Massachusetts General Hospital, Boston.

Vaccination coverage among pregnant women during the 2013-2014 flu season was 52%, only a slight increase from 51% the previous year. Coverage rates varied by age: 46% for pregnant women aged 18-24 years, 57% for those aged 24-34 years, and 53% for those aged 35-49 years.

Numerous studies have shown that the flu shot is safe during all trimesters, although the nasal spray is not recommended for pregnant women, Dr. Riley noted. Employ each doctor visit as an opportunity to offer and recommend flu vaccination. “A strong recommendation” from a health care provider has been significantly associated with increased vaccination across all demographic groups of pregnant women, she said.

Health care personnel seem to be getting the message about flu vaccination, said Dr. Schaffner. Overall, 75% of health care personnel received a flu vaccine last year, including 92% of physicians and 90% of nurses.

He exhorted health care workers to keep the trend going and to get vaccinated for their patients’ health, as well as their own.

“Immunization of health care personnel is, first and foremost, a patient safety issue,” he said.

Complete data on vaccination coverage in health care workers and patient populations were published in the CDC’s Morbidity and Mortality Weekly Report on Sept. 19 (MMWR 2014;63:805-11). Data on flu vaccine coverage in the U.S. population are available online.

[email protected]

WASHINGTON – The best way to fight the flu is to “get a flu shot this year and every year,” said Dr. Thomas Frieden.

Last year was a bad year, especially for adults aged 18-64 years, who had their highest rate of flu-related hospitalizations since the 2009 pandemic, Dr. Frieden, director of the Centers for Disease Control and Prevention, Atlanta, said at a recent press conference sponsored by the National Foundation for Infectious Diseases.

©CDC

Approximately 150 million doses of flu vaccine are expected to be available this season, and there should be plenty to go around, he emphasized.

The CDC has a three-pronged message for patients and health care providers: Get vaccinated, stay home if you are sick, and take medications if they are prescribed.

Overall vaccination coverage of the U.S. population aged 6 months and older was 46% in 2013-2014, which was a slight increase from the previous year. The upward trend is encouraging, Dr. Frieden said, especially the 65% of adults aged 65 and older and 70% of children aged 6 months to 5 years who received flu vaccination last year, but there is certainly room for improvement.

Fortunately, there are more flu vaccine options, and places to get them, than ever before, said Dr. William Schaffner, professor and chairman of the department of preventive medicine at Vanderbilt University, Nashville, past president of the NFID. Choices include the traditional intramuscular shot, an intradermal version with a smaller needle, nasal spray, an egg-free vaccine, and a high-dose vaccine especially for adults aged 65 and older, he said.

This year, for the first time, the CDC recommends the nasal spray as the preferred flu vaccination method for children aged 2-8 years if they have no contraindications, said Dr. Paul A. Offit, chief of the division of infectious diseases and director of the vaccine education center of the Children’s Hospital of Philadelphia. Parents, however, should not postpone vaccinating their children with a different vaccine if the spray is not available, since all are effective, he said.

Although flu vaccination rates in children are up, coverage of pregnant women held steady, said Dr. Laura E. Riley, medical director of labor and delivery in the obstetrics service of Massachusetts General Hospital, Boston.

Vaccination coverage among pregnant women during the 2013-2014 flu season was 52%, only a slight increase from 51% the previous year. Coverage rates varied by age: 46% for pregnant women aged 18-24 years, 57% for those aged 24-34 years, and 53% for those aged 35-49 years.

Numerous studies have shown that the flu shot is safe during all trimesters, although the nasal spray is not recommended for pregnant women, Dr. Riley noted. Employ each doctor visit as an opportunity to offer and recommend flu vaccination. “A strong recommendation” from a health care provider has been significantly associated with increased vaccination across all demographic groups of pregnant women, she said.

Health care personnel seem to be getting the message about flu vaccination, said Dr. Schaffner. Overall, 75% of health care personnel received a flu vaccine last year, including 92% of physicians and 90% of nurses.

He exhorted health care workers to keep the trend going and to get vaccinated for their patients’ health, as well as their own.

“Immunization of health care personnel is, first and foremost, a patient safety issue,” he said.

Complete data on vaccination coverage in health care workers and patient populations were published in the CDC’s Morbidity and Mortality Weekly Report on Sept. 19 (MMWR 2014;63:805-11). Data on flu vaccine coverage in the U.S. population are available online.

[email protected]

WASHINGTON – The best way to fight the flu is to “get a flu shot this year and every year,” said Dr. Thomas Frieden.

Last year was a bad year, especially for adults aged 18-64 years, who had their highest rate of flu-related hospitalizations since the 2009 pandemic, Dr. Frieden, director of the Centers for Disease Control and Prevention, Atlanta, said at a recent press conference sponsored by the National Foundation for Infectious Diseases.

©CDC

Approximately 150 million doses of flu vaccine are expected to be available this season, and there should be plenty to go around, he emphasized.

The CDC has a three-pronged message for patients and health care providers: Get vaccinated, stay home if you are sick, and take medications if they are prescribed.

Overall vaccination coverage of the U.S. population aged 6 months and older was 46% in 2013-2014, which was a slight increase from the previous year. The upward trend is encouraging, Dr. Frieden said, especially the 65% of adults aged 65 and older and 70% of children aged 6 months to 5 years who received flu vaccination last year, but there is certainly room for improvement.

Fortunately, there are more flu vaccine options, and places to get them, than ever before, said Dr. William Schaffner, professor and chairman of the department of preventive medicine at Vanderbilt University, Nashville, past president of the NFID. Choices include the traditional intramuscular shot, an intradermal version with a smaller needle, nasal spray, an egg-free vaccine, and a high-dose vaccine especially for adults aged 65 and older, he said.

This year, for the first time, the CDC recommends the nasal spray as the preferred flu vaccination method for children aged 2-8 years if they have no contraindications, said Dr. Paul A. Offit, chief of the division of infectious diseases and director of the vaccine education center of the Children’s Hospital of Philadelphia. Parents, however, should not postpone vaccinating their children with a different vaccine if the spray is not available, since all are effective, he said.

Although flu vaccination rates in children are up, coverage of pregnant women held steady, said Dr. Laura E. Riley, medical director of labor and delivery in the obstetrics service of Massachusetts General Hospital, Boston.

Vaccination coverage among pregnant women during the 2013-2014 flu season was 52%, only a slight increase from 51% the previous year. Coverage rates varied by age: 46% for pregnant women aged 18-24 years, 57% for those aged 24-34 years, and 53% for those aged 35-49 years.

Numerous studies have shown that the flu shot is safe during all trimesters, although the nasal spray is not recommended for pregnant women, Dr. Riley noted. Employ each doctor visit as an opportunity to offer and recommend flu vaccination. “A strong recommendation” from a health care provider has been significantly associated with increased vaccination across all demographic groups of pregnant women, she said.

Health care personnel seem to be getting the message about flu vaccination, said Dr. Schaffner. Overall, 75% of health care personnel received a flu vaccine last year, including 92% of physicians and 90% of nurses.

He exhorted health care workers to keep the trend going and to get vaccinated for their patients’ health, as well as their own.

“Immunization of health care personnel is, first and foremost, a patient safety issue,” he said.

Complete data on vaccination coverage in health care workers and patient populations were published in the CDC’s Morbidity and Mortality Weekly Report on Sept. 19 (MMWR 2014;63:805-11). Data on flu vaccine coverage in the U.S. population are available online.

[email protected]